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Edited by Amy McGoughAbstract Clathrin light chain (CL) b puriﬁed from bovine brain
postmicrotubule supernatant and identiﬁed by mass spectrometry
potently inhibited a catalytic activity of a major protein phospha-
tase (PP) that was copuriﬁed with microtubules and recognized
by antiPP1 antibodies. CLb similarly aﬀected the catalytic sub-
unit and holoenzyme of the PP, little inhibiting the activity of
PP2A. Although the CLb from clathrin-coated vesicles was sev-
eral hundredfold weaker than our puriﬁed CLb, the CLb in the
postmicrotubule supernatant, independent of whether it was sed-
imentable or soluble, was as active as the puriﬁed CLb. Thus
CLb may be a potent regulator of the PP.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Microtubules (MT)s are a major cytoskeleton involved in a
variety of intracellular functions such as the transport of
organelles and vesicles, often located with or near intracellular
structures [1].
Protein phosphatases (PP)s regulate functions of proteins by
dephosphorylating phosphoamino acids and are classiﬁed into
two gene families one of which includes PP1, PP2A and PP2B
[2,3]. PPs are themselves controlled by numerous regulatory
proteins and thus involved in diverse functions in cells [2].
Concerning the cytoskeletal structure, PP1 [4], PP2A [5] and
PP2B [6] were shown to promote assemblies of actin ﬁbers,
microtubules and endocytic proteins, respectively.
Approximately 50 regulatory proteins for PP1 have been
identiﬁed, including targeting-proteins that localize PP1 to spe-
ciﬁc intracellular sites and thermostable proteins that inhibit
speciﬁcally PP1 [7]. Most of the regulatory proteins have a
short conserved motif for PP1 binding, the RVxF motif, and
therefore no regulatory protein with two exceptions was shownAbbreviations: MT, microtubule; PP, protein phosphatase; CL, clath-
rin light chain
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doi:10.1016/j.febslet.2005.12.105to bind, via its motif sequence, to PP1c in a complex with the
motif sequence on another regulatory protein [7].
A major PP was isolated together with MTs up to the ﬁnal
stage of puriﬁcation and thought to be ﬁrmly associated with
MTs [8]. The PP may be regulated by constituent proteins of
MTs or other structures, thereby playing roles in functions rel-
evant to MTs. In fact, tubulin, the major component of MTs,
inhibits a catalytic activity of the MT PP [8]. This study shows
that clathrin light chain (CL) b [9] potently aﬀected the MT
PP.2. Materials and methods
2.1. Materials
MTs were puriﬁed from bovine brain by two cycles of assembly and
disassembly using the method of Shelanski et al. as described in [8] ex-
cept that 0.5 mM phenylmethanesulphonyl ﬂuoride, 1 mM benzami-
dine and 10 lg/ml leupeptin were used for the extraction. The
puriﬁed MTs and post-MT supernatant were stored at 70 C. Polyly-
sine Sepharose was purchased from Sigma (St. Louis, MO, USA).
Other materials were purchased as described [8,10].
2.2. Buﬀers
The buﬀers repeatedly used: buﬀer A [50 mM, Tris–HCl, pH 7.4;
0.2% (v/v), 2-mercaptoethanol; 0.1 mM, EDTA; 1 mg/ml, bovine ser-
um albumin]; buﬀer B [20 mM, Tris–HCl, pH 7.4; 0.1%, 2-mercap-
toethanol]; buﬀer C [20 mM, Tris–HCl, pH 7.4; 0.1%,
mercaptoethanol; 10% (v/v), glycerol]; buﬀer D [20 mM Mes, pH 6.8;
0.1%, mercaptoethanol; 10%, glycerol]. The pH was adjusted at the
temperature at which the buﬀer was used.
2.3. Assay
The assay of PP activity was performed as described [8]. One unit
(U) of PP activity was tentatively deﬁned as that amount which cata-
lyzed the release of 1 nmol phosphate per min from 32P-labeled phos-
phorylase-a at 0.5 lM (the amount corresponded to 10–20 U when
measured using the substrate at 10 lM).
Molecules aﬀecting PPs were assayed by their ability to inhibit the
phosphorylase phosphatase activities of PPs. The assay solution com-
prised PP at 20 mU/ml in buﬀer A (10 ll), 32P-labeled phosphorylase-a
(5 ll) and the molecules in dilution buﬀers (5 ll). Successive dilution of
highly puriﬁed CLb was not successful with buﬀer B (used in Fig. 1)
but tolerably accurate with buﬀer A with (in Fig. 2) or without (in
Fig. 3) Brij 35 at 0.01%. A large volume of buﬀer B was employed
for the dilution. A plot of percent inhibition of the MT PP activity
against the concentration of molecules aﬀecting PPs in the post-MT
supernatant was essentially linear up to about 40% inhibition. It was
supposed that within this range of inhibition, the concentration of
the inhibitory activity was proportional to the concentration of the
inhibitory molecules. Thus, the amount of the inhibitory moleculesblished by Elsevier B.V. All rights reserved.
Fig. 1. Puriﬁcation of MT-PP1-aﬀecting proteins from post-MT
supernatant. (A) Thermostable proteins aﬀecting MT-PP1 were
puriﬁed as described under Section 2. Elution of inhibitory activity
(d) and protein (n) is depicted. Fractions of 0.5 ml were collected.
Aldolase, bovine serum albumin and ovalbumin were used as marker
proteins. Vo indicates the void volume. (B) The thermostable proteins
in fraction 26 in A were examined by SDS–PAGE. The Rf indicates the
relative mobility. An aliquot (2.3 lg protein) was electrophoresed and
the gel stained with Brilliant blue R. Bovine serum albumin,
ovalbumin, trypsinogen, lactoglobulin and lysozyme were used as
marker proteins (top). The proteins in another aliquot (140 mU of
inhibitory activity) were precipitated by 20% trichloroacetic acid, and
the precipitate washed with acetone and electrophoresed (bottom). The
unstained gel lane was cut at a distance of 1.5 or 3 cm from the origin
and the part of the gel between the cuts was sliced into 14 pieces (about
1.1 mm in length) and the slice was extracted overnight with buﬀer B
(250 ll). The extracts were assayed for inhibitory activity.
Fig. 2. CLb potently inhibits the phosphorylase phosphatase activity
of MT-PP1. CLb of high purity as shown in Fig. 1B was examined at
the indicated concentrations for its ability to aﬀect the activity of MT-
PP1 in three preparations: MT-PP1 from the MT fraction (d), the
catalytic subunit (n) and holoenzyme (s) of MT-PP1.
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tatively expressed as 0.1 mU (the 20-ll assay solution contains 0.2 mU
of PP).
2.4. Puriﬁcation of MT PP (MT-PP1)-aﬀecting proteins (CLb) from
the post-MT supernatant
The post-MT supernatant (200 ml) was added over 10 min to 100 ml
of water heated and maintained at 75–85 C and the supernatant was
further heated for 5 min. The solution was centrifuged at 11000 · g for15 min at 4 C. All subsequent steps were performed at ambient tem-
perature except dialysis (4 C). The supernatant (38 U of inhibitory
activity) was adjusted to 20% trichloroacetic acid by adding 0.25 vol-
ume of 100% (w/v) trichloroacetic acid and centrifuged. The precipitate
was washed with acetone three times and quickly solubilized with
2.5 ml of 8 M urea. The solution was dialyzed against buﬀer B with
one change of the buﬀer. The retentate was loaded on a Mono-Q
HR5/5 column in buﬀer B and the column was developed with a 20-
ml linear salt gradient to 0.5 M NaCl in buﬀer B. The ﬂow rate was
1 ml/min. The active fractions (eluting broadly at about 340 mMNaCl,
26 U, 5 ml) were pooled and dialyzed against the buﬀer with one buﬀer
change. The retentate was chromatographed on TSK-Heparin in buﬀer
B, the column developed as described for Mono-Q except that the ﬂow
rate was 0.5 ml/min. The active fractions (at 190 mM NaCl, 5.0 U,
2.5 ml) were pooled, adjusted to 20% trichloroacetic acid, and centri-
fuged; and the pellet washed with acetone. The dried pellet was dis-
solved in 50 ll of 8 M urea and the solution was diluted with 450 ll
of buﬀer B containing 0.15 M NaCl and chromatographed on Supe-
rose-12 in buﬀer B containing 0.15 M NaCl with a ﬂow rate of
0.25 ml/min.
2.5. Partial puriﬁcation of CLb from a soluble or sedimentable clathrin
fraction of the post-MT supernatant
The post-MT supernatant (10 ml) was dialyzed at 4 C against
5 mM, Tris–HCl, pH 7.4; 0.1%, mercaptoethanol; and 0.15 M NaCl
with four buﬀer changes and centrifuged at 105000 · g for 70 min at
4 C. The resulting soluble fraction was saved and the sedimentable
fraction was suspended in the original volume. The sedimentable and
soluble fractions were separately diluted at 37 C with buﬀer B to
75 ml and heat treated at 83–92 C for 10 min. The denatured proteins
were removed by centrifugation and proteins in the resulting superna-
tants were trichloroacetic-acid-precipitated, urea-solubilized, and chro-
matographed on Mono-Q as described for the puriﬁcation of CLb
from the post-MT supernatant. Fractions of 0.5 ml were collected
for the Mono-Q eluate.
2.6. Preparation of a major MT-PP (MT-PP1) and a major post-MT
supernatant-PP2A
A major MT PP that was previously proposed to be PP2A1 of the
MT fraction [8] was highly puriﬁed as below. All operations were con-
ducted at 2–6 C except FPLC (at ambient temperature). MTs (32 ml,
400 mg protein) from 1 kg of bovine brain were dialyzed against
80 mM MOPS, pH 7.0; 0.8 mM, MgCl2; 0.8 mM, EGTA; and
0.23 M, NaCl with one buﬀer change and the MTs (37 ml, 3.6 U of
PP activity) were applied to a DEAE-cellulose column (4.5 · 3.5 cm)
in the buﬀer. The ﬂow-through fraction (74 ml, 5.7 U of activity)
was diluted 4-fold with buﬀer C and chromatographed on another
DEAE-cellulose column (3 · 2.5 cm) using a 200-ml linear salt gradient
to 0.5 M NaCl in buﬀer C. The active fractions (eluting at 0.22 M
Fig. 3. CLb from either a soluble or sedimentable clathrin fraction in the post-MT supernatant is similar to the puriﬁed CLb in its inhibitory eﬀect on
MT-PP1. The aliquots of Mono-Q-eluate containing CLb that was partially puriﬁed from the sedimentable (A,B) or soluble (C,D) clathrin fraction
as described under Section 2 were pooled (at 312.5–400 mM NaCl: eluate in fractions 25–32 for A and C; at 412.5–500 mM NaCl: eluate in fractions
33–40 for B and D; 800 ll each pool) and adjusted to 20% trichloroacetic acid, and the precipitated proteins washed with acetone and dissolved in
80 ll of buﬀer B. The dissolved proteins were appropriately diluted to give about 70–90% inhibition in the MT-PP1 inhibition assay and further
diluted 2-fold successively. The dilutions were assayed at the indicated arbitrary concentrations for the eﬀect on MT-PP1 (the upper diagram). CL in
quantities present in the 20 ll assay solutions was also analyzed by immunoblotting using an anti-CL antibody (the lower diagram). The numbers in
parentheses indicate the amounts (lU) calculated from the inhibition (%) at concentration 4 (for A,C,D) or 8 (for B). In E, CLb used in the MT-PP1
inhibition assay shown in Fig. 2 was electrophoresed and immunoblotted as above. The CLb in quantities present in the 20 ll assay solutions at the
indicated concentrations was analyzed and the amounts were expressed in activity (lU) calculated from its speciﬁc activity (EC50 of 1 nM, 200 U/mg)
in parentheses and in mass (ng) in square brackets. Greater inhibition at arbitrary concentration 8 than that at 16 by the eluate at 412.5–500 mM
NaCl of soluble clathrin was conﬁrmed in other identically-diluted solutions.
A. Hiraga et al. / FEBS Letters 580 (2006) 1425–1430 1427NaCl) were pooled (45 ml, 3.4 U), diluted 2-fold with buﬀer C, and ap-
plied to a polylysine Sepharose column (2.5 · 1.5 cm). The column was
washed with buﬀer C containing 0.1 M NaCl and the MT PP waseluted with buﬀer C containing 0.24 M NaCl. The active fractions were
pooled (11 ml, 2.2 U), diluted with 15 ml of buﬀer C, and chromato-
graphed on Mono-Q using a 20-ml linear salt gradient to 0.5 M NaCl
1428 A. Hiraga et al. / FEBS Letters 580 (2006) 1425–1430in buﬀer C. The active fractions (eluting at 306 mM NaCl) were
pooled, diluted 4-fold with buﬀer D, and chromatographed on TSK-
Heparin using a 20-ml linear salt gradient to 0.5 M NaCl in buﬀer D.
A major PP2A of the post-MT supernatant, which was proposed to
be cytosolic PP2A1 [8], was highly puriﬁed. The post-MT supernatant
(200 ml) was adjusted to pH 7.4 with 1 N NaOH, diluted to 500 ml
with buﬀer C containing 0.1 M NaCl, and applied to a DEAE cellulose
column (4 · 4 cm) in buﬀer C. The column was washed with 500 ml of
buﬀer C containing 0.1 M NaCl and thereafter the PP2A was eluted
with buﬀer C containing 0.23 M NaCl. The eluate (90 ml) was diluted
2-fold with buﬀer C and applied to a polylysine Sepharose column
(4 · 1.5 cm) in buﬀer C. The active fraction (eluted at 0.24 M NaCl)
was further puriﬁed by successive chromatography on Mono-Q and
TSK-Heparin as described for the MT PP.
PP activities from the MTs and cytosol were almost identical in salt
concentrations required for elution of the major peak of the activity
from each of the above chromatographic columns up to the Mono-Q
step. However, the PP activities both resolved into two major peaks
at 235 and 380 mM NaCl with the chromatography on TSK-Heparin.
The PP at 380 mM NaCl was recognized by anti-PP1 (BD Transduc-
tion Laboratories 610373) and anti-PP1c (Santa Cruz Biotechnology
sc-6108) but not anti-PP2A (BD Transduction Laboratories 610555)
antibodies and inhibited by okadaic acid with an IC50 of 200 nM.
Thus it is regarded as PP1 although inhibitor 2 discriminating PP1
from the PP1 subfamily [3] was not tested. The PP at 235 mM NaCl
was recognized by the anti-PP2A but not anti-PP1 antibody and highly
sensitive to okadaic acid (an IC50 of 0.05 nM). It is PP2A. The PP 1
and PP2A were each the major component of the MT and cytosolic
PPs, respectively, and the PP1 is hereafter referred to as MT-PP1.
2.7. Preparation of the catalytic subunit and holoenzyme of MT-PP1
Aliquots containing MT-PP1 from the post-MT supernatant, which
was rechromatographed on TSK-Heparin under the same conditions
as those for the ﬁrst chromatography, were incubated with 0 and
3 M NaCl at 4 C for 2.5 h and, respectively, gel ﬁltrated with 0.1
and 1 M NaCl on Superose 12. The catalytic subunit was dissociated
from the holoenzyme with 3 M NaCl and eluted with 1 M NaCl at
the position of a elution volume/void volume of 1.88 (about 30 kDa)
while the holoenzyme eluted with 0.1 M NaCl at the position of 1.52
(about 300 kDa).
2.8. Other analytical procedures
Protein determination and SDS–PAGE (on a 15% gel) were per-
formed according to, respectively, Bradford and Laemmli ([10] for ref-
erences). Immunoblotting was performed by semidrying blotting usingTable 1
Identiﬁcation of the puriﬁed proteins of 29 and 32 kDa as CLb
Masses Amino acid
Measured Matched Residue nos.
1072.5893 1072.5639 95–103
1200.6680 1200.6588 95–104
1031.5634 1031.5387 104–110
903.4668 903.4437 105–110
1031.5634 1031.5387 105–111
1130.6360 1130.6170 112–121
977.4810 977.4515 122–128
993.4675 993.4464 122–128
1217.6077 1217.5915 133–141
1089.5201 1089.4965 134–141
1089.5201 1089.5540 142–150
2888.3996 2888.4358 155–180
2461.2205 2461.1927 159–180
3991.9487 3991.8766 159–193
1549.7470 1549.7022 181–193
1191.6001 1191.5832 194–203
701.4088 701.3946 223–228#
The puriﬁed MT-PP1-aﬀecting proteins in fraction 26 shown in Fig. 1 were ex
by mass spectrometric analysis as described [20]. The three highest ranked pr
of bovine brain, human brain and bovine lymphocyte isoforms (NCBI accessi
shown in the table. The boldface denotes the brain-speciﬁc insertion sequ
derivative and the C-terminus [12], respectively.the buﬀer of Bjerrum and Schafer–Nielsen [11], followed by analysis
with an ECL-plus Western blotting detection system (Amersham bio-
sciences; Little Chalfont, England). A mouse monoclonal antibody
against clathrin light chain (Santa Cruz Biotechnology, sc-12735, San-
ta Cruz, CA, USA) and a goat antibody (horseradish peroxidase con-
jugate) against mouse immunoglobulins (Tago, number 6450,
Burlingame, CA, USA) were used at a 1000-fold and 5000-fold dilu-
tion, respectively.3. Results
3.1. CLb puriﬁed from post-MT supernatant potently inhibits
the phosphorylase phosphatase activities of the catalytic
subunit and holoenzyme of MT-PP1
At the ﬁnal stage in the puriﬁcation of MT-PP-aﬀecting mol-
ecules, the inhibitory activity (Fig. 1A) and two proteins of 32
and 29 kDa (not shown) coeluted at the position of a 67-kDa
marker protein from Superose-12. SDS–PAGE analysis of the
eluate also showed that the activities coincided with the two
proteins (Fig. 1B). Mass spectrometric analysis of tryptic pep-
tides of the two proteins revealed 15 masses matching 17 tryp-
tic peptides theoretically produced from the brain isoform of
bovine clathrin light chain b (Table 1). The analysis indicated
no proteins other than CLb. Therefore, the two proteins were
both identiﬁed as CLb, a subunit of clathrin triskelion [9,12].
Unusual properties reported for CLb were observed: an al-
most identical diﬀerence in molecular mass inferred from the
above two methods ([13] and Fig. 1) and incorrectly large
molecular masses indicated by electrophoretic mobilities in
SDS–PAGE ([9] and estimation for brain CLb of 25.1 kDa
[12] to be 29 and 32 kDa in Fig. 1). Since the 29-kDa protein
was seen in the puriﬁed CLb but not its crude preparations
(see Fig. 3), it is likely to be a proteolytic product of brain
CLb and not non-(severely)-proteolyzed non-brain CLb
(23.1 kDa [12]).
The puriﬁed CLb similarly inhibited the phosphorylase
phosphatase activities of the catalytic subunit and holoenzyme
of MT-PP1, 50% inhibition occurring at 1 nM (Fig. 2). CLbSequences
(R)LTQEPESIR(K)
(R)LTQEPESIRK(W)
(R)KWREEQR(K)
(K)WREEQR(K)
(K)WREEQRK(R)
(K)RLQELDAASK(V)
(K)VMEQEWR(E)
(K)VMEQEWR(E)*
(K)KDLEEWNQR(Q)
(K)DLEEWNQR(Q)
(R)QSEQVEKNK(I)
(R)IADKAFYQQPDADIIGYVASEEAFVK(E)
(K)AFYQQPDADIIGYVASEEAFVK(E)
(K)AFYQQPDADIIGYVASEEAFVKESKEETPGTEWEK(V)
(K)ESKEETPGTEWEK(V)
(K)VAQLCDFNPK(S)
(K)QTPLSR(–)
cised in one gel piece and subjected to in-gel tryptic digestion followed
otein items matched by the measured peptide ions were CLb molecules
on numbers 116504, 6005995 and 514, respectively), the ﬁrst of which is
ence. The asterisk (*) and sharp (#) indicate a methionine sulphone
A. Hiraga et al. / FEBS Letters 580 (2006) 1425–1430 1429little inhibited the activities of the PP2A tested (not shown).
Catalytic subunits of PP1 from the ethanol-treated muscle-
(but not brain) extract [14] were roughly fourfold less potently
aﬀected by CLb and were not suitable for locating CLb eluted
from the Mono-Q column (not shown).
3.2. CLb from either soluble or sedimentable clathrin can
potently aﬀect MT-PP1
The CLb that was prepared from clathrin vesicles puriﬁed by
standard procedures [15] and identiﬁed by chemical amino acid
sequence analysis (as in [10]) was several hundredfold less po-
tent than our puriﬁed CLb (not shown) when heat-treated and
Mono-Q-chromatographed as in this study. Clathrin vesicles
are formed and sedimented in the absence of a high concentra-
tion (0.5 M) of protonated amines such as Tris [15]; anti-CL
antibody-recognized molecules in the extract used (no Tris
but 25% glycerol [8]) were almost all recovered in the post-
MT supernatant (not shown). The molecules in the post-MT
supernatant in 5 mM Tris buﬀer without glycerol, however,
could be mostly sedimented (not shown).
When the sedimentable or soluble clathrin fraction was heat-
treated and Mono-Q-chromatographed as in the puriﬁcation
of CLb, the antibody-recognized molecules and MT-PP-1
inhibitory activities from each fraction eluted as broad peaks
at 310–500 mM NaCl (not shown). The heated solution, when
directly chromatographed without acid precipitation followed
by urea-solubilization, gave very similar results (not shown).
The inhibitory activity of each peak from either the soluble
or sedimentable fraction was similar to that of CLb puriﬁed
from the post-MT supernatant despite the presence of a 37-
kDa protein most likely to be CLa [9,13]: 60–90% inhibition
of MT-PP1 activity was produced by the CLb at the concen-
tration where it was marginally detected by immunoblotting
under the conditions (Fig. 3, arbitrary concentration 16 in B,
8 in C and D; 2.4 nM in E).4. Discussion
The MT-PP1-aﬀecting proteins puriﬁed from post-MT
supernatant coincide with CLb of high purity in chromato-
graphic and electrophoretic behavior (Fig. 1) and sediment-
ability without abundant Tris. Besides, the observed aﬃnity
of CLb for MT-PP1 is high (EC50 of 1 nM) (Fig. 2). Further-
more, ‘‘speciﬁc activities’’ (activities related to the immuno-
blotting intensity) of the four CLb pools from soluble or
sedimentable clathrin and of the puriﬁed CLb are similar
(Fig. 3). Therefore, it is very unlikely that other proteins copu-
riﬁed with our CLb are responsible for the observed inhibition
of MT-PP1.
CLb does not have the known PP1 binding motif [7,12]
but potently aﬀects MT-PP1. Thus, it may eﬀectively regu-
late the PP1 catalytic subunits complexed to its regulatory
proteins via the motif. Consistent with this idea, it aﬀects
similarly the catalytic subunit and holoenzyme of MT-PP1
(Fig. 2).
There was a great diﬀerence in potency between CLb from
post-MT supernatant and classical clathrin vesicles. It was ob-
served that incubation of the brain extract with ATP and glyc-
erol at 37 C roughly doubled MT-PP1 inhibitory activities
therein and that our puriﬁed CLb is unstable and lost all of
the inhibitory activity and became insoluble after two-yearstorage at 70 C. Enzymatic modiﬁcation and/or structural
instability of CLb may underlie the great diﬀerence.
Brain clathrin vesicles are thought to function mainly at the
plasma membrane and participate in synaptic vesicle recycling
[9], but the transport of clathrin-coated vesicles at the site is
considered to be dependent on actin not MTs [1]. However,
tubulin was previously identiﬁed as a major component of
clathrin-coated vesicles and evidence for the involvement of
MTs in clathrin-mediated endocytosis has been increasing
([16–18] and references therein). This study shows that CLb
in soluble triskelions and/or assembled vesicles (Fig. 3) also
likely interacts with PP1 on MTs in cells. The presence of sol-
uble CLb molecules with MTs or MT-PP1 (unpublished re-
sults) may support this notion.
sds22 [7], CPI17 [7] and Scapinin (Phacts1–4) [19] that lack
the known PP-1-binding motif strongly interact with PP1.
Identiﬁcation of the sites/motif for PP-1-binding on CLb in
addition to these proteins may reveal as yet unknown princi-
ples for the regulation of the PP1 family.
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